Acurx Pharmaceuticals Future Growth
Future criteria checks 0/6
Acurx Pharmaceuticals is forecast to grow earnings and revenue by 7.4% and 68% per annum respectively while EPS is expected to decline by 12.4% per annum.
Key information
7.4%
Earnings growth rate
-12.4%
EPS growth rate
| Biotechs earnings growth | 20.7% |
| Revenue growth rate | 68.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 Mar 2024 |
Recent future growth updates
No updates
Recent updates
Acurx Sell-Off Presents Opportunity Before Upcoming Data Release
Jan 22Here's Why We're Not Too Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
Oct 30
Is Acurx Pharmaceuticals (NASDAQ:ACXP) In A Good Position To Invest In Growth?
Jul 15Is Acurx Pharmaceuticals (NASDAQ:ACXP) In A Good Position To Deliver On Growth Plans?
Mar 04Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
Nov 16Acurx, Pharmaceuticals drops 8.8%, announces $4.25M direct offering
Jul 25Here's Why We're Watching Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
May 13Here's Why We're Not Too Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Situation
Jan 22Companies Like Acurx Pharmaceuticals (NASDAQ:ACXP) Can Afford To Invest In Growth
Sep 30New Antibiotics Needed For Drug-Resistant Infections, Acurx Pharmaceuticals May Have The Answers
Aug 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 16 | -17 | N/A | 32 | 3 |
| 12/31/2025 | N/A | -26 | N/A | -11 | 3 |
| 12/31/2024 | N/A | -16 | N/A | -9 | 3 |
| 12/31/2023 | N/A | -15 | -10 | -10 | N/A |
| 9/30/2023 | N/A | -13 | -7 | -7 | N/A |
| 6/30/2023 | N/A | -13 | -7 | -7 | N/A |
| 3/31/2023 | N/A | -12 | -8 | -8 | N/A |
| 12/31/2022 | N/A | -12 | -8 | -8 | N/A |
| 9/30/2022 | N/A | -11 | -8 | -8 | N/A |
| 6/30/2022 | N/A | -13 | -8 | -8 | N/A |
| 3/31/2022 | N/A | -14 | -6 | -6 | N/A |
| 12/31/2021 | N/A | -13 | -5 | -5 | N/A |
| 9/30/2021 | N/A | -11 | -4 | -4 | N/A |
| 6/30/2021 | N/A | -8 | -3 | -3 | N/A |
| 3/31/2021 | N/A | -5 | -3 | -3 | N/A |
| 12/31/2020 | N/A | -5 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACXP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ACXP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ACXP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ACXP is forecast to have no revenue next year.
High Growth Revenue: ACXP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ACXP's Return on Equity is forecast to be high in 3 years time